In those cases, each standard deviation increase in VMR was tied to a 50% higher likelihood of experiencing a major adverse ...

Previous knowledge on melatonin use for pulmonary arterial hypertension has primarily been gathered from animal studies, with ...

Regardless of chronic obstructive pulmonary disease status, finerenone mitigates clinical events and symptoms in patients with HFmrEF or HFpEF.

There is increased risk for pulmonary hypertension in patients with both atrial fibrillation and incident venous thromboembolism.

Between 14 days and 1 day out from an acute exacerbation of COPD, a digital inhaler measured significant drops in inhalation ...

Theravance Biopharma’s partner Viatris has received China's NMPA approval for Yupelri inhalation solution for maintenance treatment of COPD.

Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.

Background The National Early Warning Score 2 (NEWS2) includes two oxygen saturation scales; the second adjusts target saturations to 88%–92% for those with hypercapnic respiratory failure. Using this ...